Stay updated on Parpvax: Niraparib + Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.

Latest updates to the Parpvax: Niraparib + Immunotherapy Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag has been updated to v3.5.4, signaling a new version of the page; the displayed study information remains unchanged.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s footer revision tag was bumped from v3.5.2 to v3.5.3, indicating a minor update to the ClinicalTrials.gov site version without changing the study content displayed.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision v3.5.0 has been added, replacing the previous v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2. This is a non-content update and does not affect study details or user-facing functionality.SummaryDifference0.1%

- Check98 days agoChange DetectedA new site revision banner shows Revision: v3.4.2, and the government funding status notice has been removed.SummaryDifference0.4%

Stay in the know with updates to Parpvax: Niraparib + Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.